 Paul MacLean
Concepts (561)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 55 | 2025 | 2863 | 5.330 |
Why?
| | Weight Gain | 26 | 2023 | 505 | 4.820 |
Why?
| | Energy Metabolism | 32 | 2024 | 836 | 4.760 |
Why?
| | Weight Loss | 25 | 2025 | 724 | 4.420 |
Why?
| | Physical Conditioning, Animal | 9 | 2020 | 229 | 2.470 |
Why?
| | Rats, Wistar | 19 | 2024 | 398 | 2.360 |
Why?
| | Energy Intake | 18 | 2025 | 455 | 2.290 |
Why?
| | Dietary Fats | 14 | 2019 | 301 | 1.930 |
Why?
| | Caloric Restriction | 8 | 2025 | 108 | 1.820 |
Why?
| | Ovariectomy | 10 | 2024 | 139 | 1.770 |
Why?
| | Body Weight | 16 | 2024 | 932 | 1.580 |
Why?
| | Lactation | 8 | 2020 | 170 | 1.550 |
Why?
| | Adipose Tissue | 15 | 2022 | 592 | 1.540 |
Why?
| | Diet, High-Fat | 15 | 2023 | 238 | 1.420 |
Why?
| | Milk, Human | 6 | 2022 | 148 | 1.380 |
Why?
| | Body Composition | 12 | 2024 | 657 | 1.280 |
Why?
| | Rats | 34 | 2024 | 5173 | 1.240 |
Why?
| | Appetite | 2 | 2020 | 56 | 1.210 |
Why?
| | Muscle, Skeletal | 20 | 2022 | 1640 | 1.170 |
Why?
| | Ovary | 4 | 2024 | 214 | 1.100 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 47 | 1.090 |
Why?
| | Diet, Fat-Restricted | 6 | 2015 | 79 | 1.080 |
Why?
| | Animals | 73 | 2024 | 34600 | 1.030 |
Why?
| | Lipid Metabolism | 9 | 2017 | 493 | 1.020 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2017 | 137 | 1.010 |
Why?
| | Motor Activity | 3 | 2019 | 669 | 1.000 |
Why?
| | Adipocytes | 6 | 2022 | 204 | 0.980 |
Why?
| | Appetite Regulation | 2 | 2017 | 26 | 0.920 |
Why?
| | Adaptation, Physiological | 7 | 2018 | 515 | 0.890 |
Why?
| | Biomedical Research | 3 | 2023 | 647 | 0.860 |
Why?
| | Liver | 11 | 2024 | 1833 | 0.840 |
Why?
| | Cholesterol | 5 | 2019 | 406 | 0.830 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 239 | 0.810 |
Why?
| | Awards and Prizes | 1 | 2023 | 62 | 0.790 |
Why?
| | Vasopressins | 3 | 2021 | 62 | 0.790 |
Why?
| | Lipoprotein Lipase | 3 | 2021 | 58 | 0.790 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2023 | 307 | 0.790 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 16 | 0.790 |
Why?
| | Estrogens | 3 | 2018 | 354 | 0.790 |
Why?
| | Eating | 5 | 2022 | 367 | 0.780 |
Why?
| | Breast Feeding | 5 | 2022 | 422 | 0.780 |
Why?
| | Lipogenesis | 3 | 2019 | 59 | 0.780 |
Why?
| | Mammary Neoplasms, Experimental | 3 | 2021 | 66 | 0.750 |
Why?
| | Mammary Glands, Animal | 5 | 2019 | 124 | 0.750 |
Why?
| | Glycoproteins | 5 | 2005 | 337 | 0.730 |
Why?
| | Insulin | 19 | 2022 | 2320 | 0.730 |
Why?
| | Receptor, Insulin | 3 | 2015 | 100 | 0.720 |
Why?
| | Estradiol | 1 | 2024 | 497 | 0.700 |
Why?
| | Exercise | 10 | 2019 | 1947 | 0.670 |
Why?
| | Oxygen Consumption | 5 | 2019 | 675 | 0.670 |
Why?
| | Milk | 5 | 2019 | 120 | 0.660 |
Why?
| | Thermogenesis | 2 | 2019 | 44 | 0.660 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 190 | 0.650 |
Why?
| | Physical Exertion | 3 | 2011 | 212 | 0.650 |
Why?
| | Female | 61 | 2025 | 68510 | 0.650 |
Why?
| | Cold Temperature | 2 | 2019 | 153 | 0.650 |
Why?
| | Carrier Proteins | 6 | 2005 | 732 | 0.640 |
Why?
| | Overweight | 4 | 2022 | 526 | 0.620 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 563 | 0.620 |
Why?
| | Sex Characteristics | 3 | 2021 | 727 | 0.610 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 110 | 0.600 |
Why?
| | Fasting | 6 | 2025 | 264 | 0.600 |
Why?
| | Menopause | 2 | 2019 | 303 | 0.590 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 52 | 0.590 |
Why?
| | Breast Neoplasms | 6 | 2022 | 2150 | 0.580 |
Why?
| | Adipogenesis | 1 | 2017 | 49 | 0.560 |
Why?
| | Cortical Bone | 1 | 2017 | 18 | 0.550 |
Why?
| | Organic Cation Transport Proteins | 1 | 2017 | 26 | 0.540 |
Why?
| | Adiposity | 5 | 2016 | 505 | 0.540 |
Why?
| | Diet, Reducing | 4 | 2021 | 84 | 0.540 |
Why?
| | Leptin | 6 | 2022 | 218 | 0.540 |
Why?
| | Ibuprofen | 1 | 2017 | 80 | 0.540 |
Why?
| | Mice | 33 | 2022 | 16644 | 0.530 |
Why?
| | Metformin | 2 | 2018 | 313 | 0.530 |
Why?
| | Placenta | 1 | 2023 | 716 | 0.530 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 95 | 0.510 |
Why?
| | Osteogenesis | 2 | 2017 | 178 | 0.510 |
Why?
| | Supraoptic Nucleus | 1 | 2015 | 4 | 0.510 |
Why?
| | Bone Density | 1 | 2019 | 477 | 0.500 |
Why?
| | Fructose | 5 | 2021 | 107 | 0.490 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 429 | 0.490 |
Why?
| | Gene Expression Regulation | 9 | 2021 | 2508 | 0.480 |
Why?
| | Oxytocin | 1 | 2015 | 48 | 0.480 |
Why?
| | Diet | 9 | 2023 | 1204 | 0.480 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 88 | 0.470 |
Why?
| | Therapies, Investigational | 1 | 2014 | 14 | 0.470 |
Why?
| | Mothers | 4 | 2018 | 729 | 0.470 |
Why?
| | Male | 56 | 2025 | 63194 | 0.450 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 343 | 0.440 |
Why?
| | Fatty Acids | 8 | 2022 | 415 | 0.440 |
Why?
| | Transcription Factors | 12 | 2019 | 1632 | 0.430 |
Why?
| | Fructokinases | 5 | 2021 | 31 | 0.420 |
Why?
| | Basal Metabolism | 3 | 2021 | 57 | 0.420 |
Why?
| | Monosaccharide Transport Proteins | 3 | 2002 | 49 | 0.420 |
Why?
| | Insulin Resistance | 8 | 2022 | 1167 | 0.420 |
Why?
| | Disease Models, Animal | 10 | 2021 | 3953 | 0.410 |
Why?
| | Fatty Liver | 5 | 2018 | 232 | 0.410 |
Why?
| | Overnutrition | 1 | 2012 | 30 | 0.400 |
Why?
| | Blood Glucose | 10 | 2019 | 2096 | 0.390 |
Why?
| | Anorexia Nervosa | 1 | 2013 | 75 | 0.390 |
Why?
| | Pregnancy | 9 | 2023 | 6375 | 0.390 |
Why?
| | Humans | 63 | 2025 | 129116 | 0.390 |
Why?
| | Diabetes Mellitus | 6 | 2018 | 1004 | 0.380 |
Why?
| | Recurrence | 4 | 2019 | 1003 | 0.380 |
Why?
| | Estrous Cycle | 1 | 2010 | 21 | 0.350 |
Why?
| | Body Mass Index | 11 | 2025 | 2266 | 0.350 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 345 | 0.350 |
Why?
| | Lipoproteins | 3 | 2000 | 171 | 0.350 |
Why?
| | RNA, Messenger | 10 | 2019 | 2676 | 0.350 |
Why?
| | Homeostasis | 7 | 2015 | 605 | 0.350 |
Why?
| | Acetyl-CoA Carboxylase | 4 | 2014 | 33 | 0.340 |
Why?
| | Estrogen Receptor alpha | 2 | 2018 | 134 | 0.330 |
Why?
| | Glucose | 10 | 2023 | 983 | 0.330 |
Why?
| | Vitamin D | 1 | 2013 | 381 | 0.330 |
Why?
| | Calorimetry, Indirect | 5 | 2021 | 80 | 0.320 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2023 | 25 | 0.320 |
Why?
| | National Institutes of Health (U.S.) | 2 | 2023 | 125 | 0.310 |
Why?
| | Behavior Therapy | 2 | 2021 | 236 | 0.310 |
Why?
| | Gastrointestinal Microbiome | 3 | 2023 | 636 | 0.310 |
Why?
| | Dietary Carbohydrates | 5 | 2019 | 152 | 0.300 |
Why?
| | Time Factors | 10 | 2019 | 6518 | 0.290 |
Why?
| | Promoter Regions, Genetic | 5 | 2017 | 1200 | 0.280 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 20 | 0.280 |
Why?
| | Neurons | 1 | 2015 | 1456 | 0.280 |
Why?
| | Mice, Knockout | 12 | 2021 | 2765 | 0.270 |
Why?
| | Mammary Glands, Human | 2 | 2020 | 64 | 0.270 |
Why?
| | Triglycerides | 8 | 2019 | 524 | 0.270 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 2060 | 0.260 |
Why?
| | Transplantation, Autologous | 1 | 2007 | 215 | 0.260 |
Why?
| | Adult | 29 | 2025 | 35510 | 0.260 |
Why?
| | Mice, Inbred C57BL | 15 | 2021 | 5284 | 0.260 |
Why?
| | Lymphoma | 1 | 2007 | 194 | 0.260 |
Why?
| | Dehydration | 2 | 2016 | 50 | 0.260 |
Why?
| | Adenocarcinoma | 1 | 2012 | 889 | 0.250 |
Why?
| | Multiple Myeloma | 1 | 2007 | 126 | 0.250 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2437 | 0.250 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 169 | 0.250 |
Why?
| | Epithelium | 2 | 2019 | 306 | 0.250 |
Why?
| | Signal Transduction | 6 | 2022 | 4838 | 0.240 |
Why?
| | Metabolic Syndrome | 3 | 2021 | 340 | 0.240 |
Why?
| | Muscle Proteins | 4 | 2012 | 229 | 0.240 |
Why?
| | Photoperiod | 2 | 2019 | 46 | 0.240 |
Why?
| | Leukemia | 1 | 2007 | 229 | 0.240 |
Why?
| | DNA-Binding Proteins | 7 | 2019 | 1423 | 0.220 |
Why?
| | Feeding Behavior | 4 | 2018 | 618 | 0.220 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 38 | 0.220 |
Why?
| | Animals, Newborn | 3 | 2017 | 805 | 0.220 |
Why?
| | Weight Reduction Programs | 2 | 2025 | 111 | 0.220 |
Why?
| | Physical Fitness | 2 | 2016 | 203 | 0.220 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2019 | 283 | 0.220 |
Why?
| | Resistance Training | 3 | 2017 | 153 | 0.210 |
Why?
| | Adiponectin | 4 | 2022 | 234 | 0.210 |
Why?
| | Cholesterol Ester Transfer Proteins | 5 | 2005 | 18 | 0.210 |
Why?
| | Transcriptome | 2 | 2024 | 883 | 0.210 |
Why?
| | Hospitalization | 1 | 2013 | 2077 | 0.210 |
Why?
| | Fetal Development | 2 | 2023 | 283 | 0.210 |
Why?
| | Sequence Analysis, RNA | 3 | 2021 | 428 | 0.210 |
Why?
| | Transcriptional Activation | 2 | 2002 | 356 | 0.210 |
Why?
| | Arteriosclerosis | 1 | 2003 | 88 | 0.210 |
Why?
| | Feces | 3 | 2021 | 437 | 0.210 |
Why?
| | Financing, Organized | 1 | 2023 | 34 | 0.210 |
Why?
| | Cell Proliferation | 3 | 2017 | 2347 | 0.210 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 1002 | 0.200 |
Why?
| | Parturition | 1 | 2023 | 70 | 0.200 |
Why?
| | Exercise Tolerance | 3 | 2016 | 269 | 0.190 |
Why?
| | Tamoxifen | 3 | 2021 | 200 | 0.190 |
Why?
| | Faculty | 1 | 2023 | 137 | 0.190 |
Why?
| | Postmenopause | 4 | 2022 | 370 | 0.190 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1353 | 0.190 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 51 | 0.190 |
Why?
| | Malus | 1 | 2021 | 11 | 0.180 |
Why?
| | Mentors | 1 | 2023 | 180 | 0.180 |
Why?
| | Polyphenols | 1 | 2021 | 18 | 0.180 |
Why?
| | Child Development | 2 | 2018 | 453 | 0.180 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 19 | 0.180 |
Why?
| | Disease Progression | 4 | 2018 | 2613 | 0.180 |
Why?
| | Thinness | 3 | 2021 | 90 | 0.180 |
Why?
| | Middle Aged | 21 | 2025 | 31074 | 0.180 |
Why?
| | Hygromycin B | 1 | 2000 | 1 | 0.180 |
Why?
| | Liver X Receptors | 2 | 2019 | 30 | 0.180 |
Why?
| | Cinnamates | 1 | 2000 | 9 | 0.180 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2021 | 161 | 0.170 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 4 | 0.170 |
Why?
| | Hyperinsulinism | 1 | 2001 | 119 | 0.170 |
Why?
| | Sheep | 1 | 2023 | 829 | 0.170 |
Why?
| | Animal Feed | 2 | 2019 | 52 | 0.170 |
Why?
| | Kynurenic Acid | 1 | 2020 | 17 | 0.170 |
Why?
| | Fruit | 1 | 2021 | 131 | 0.170 |
Why?
| | Transcription, Genetic | 7 | 2017 | 1403 | 0.170 |
Why?
| | Random Allocation | 2 | 2019 | 346 | 0.170 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 380 | 0.170 |
Why?
| | Starch | 1 | 2019 | 22 | 0.160 |
Why?
| | Nutritive Value | 1 | 2019 | 36 | 0.160 |
Why?
| | Membrane Proteins | 3 | 2015 | 1109 | 0.160 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 15 | 0.160 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 29 | 0.160 |
Why?
| | Cattle | 2 | 2019 | 962 | 0.160 |
Why?
| | Weaning | 1 | 2019 | 48 | 0.160 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 97 | 0.160 |
Why?
| | Metabolic Diseases | 2 | 2018 | 107 | 0.160 |
Why?
| | Rats, Sprague-Dawley | 8 | 2015 | 2245 | 0.160 |
Why?
| | Analysis of Variance | 4 | 2016 | 1271 | 0.160 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2020 | 174 | 0.150 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 39 | 0.150 |
Why?
| | Mice, Transgenic | 7 | 2017 | 2079 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2018 | 45 | 0.150 |
Why?
| | Aromatase | 1 | 2018 | 31 | 0.150 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 30 | 0.150 |
Why?
| | Leukocytes, Mononuclear | 1 | 2021 | 538 | 0.150 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 195 | 0.150 |
Why?
| | Perilipin-1 | 1 | 2017 | 16 | 0.150 |
Why?
| | Rest | 1 | 2018 | 123 | 0.150 |
Why?
| | Glycogen | 6 | 2010 | 55 | 0.150 |
Why?
| | Fetal Growth Retardation | 1 | 2023 | 543 | 0.150 |
Why?
| | Models, Animal | 1 | 2019 | 367 | 0.150 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 36 | 0.140 |
Why?
| | Ghrelin | 2 | 2018 | 33 | 0.140 |
Why?
| | Postpartum Period | 2 | 2020 | 330 | 0.140 |
Why?
| | Diglycerides | 1 | 2018 | 61 | 0.140 |
Why?
| | Cell Size | 1 | 2017 | 87 | 0.140 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 622 | 0.140 |
Why?
| | Germ Layers | 1 | 2017 | 7 | 0.140 |
Why?
| | Sucrose | 2 | 2018 | 95 | 0.140 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 67 | 0.140 |
Why?
| | Sphingolipids | 1 | 2018 | 69 | 0.140 |
Why?
| | Gastrulation | 1 | 2017 | 10 | 0.140 |
Why?
| | Reperfusion Injury | 1 | 2020 | 263 | 0.140 |
Why?
| | Organic Cation Transporter 2 | 1 | 2017 | 8 | 0.140 |
Why?
| | Running | 1 | 2019 | 228 | 0.140 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 60 | 0.140 |
Why?
| | Interdisciplinary Communication | 1 | 2018 | 187 | 0.140 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 14 | 0.140 |
Why?
| | Glaucoma | 1 | 2020 | 216 | 0.140 |
Why?
| | Chromatography, Gas | 1 | 2016 | 31 | 0.140 |
Why?
| | Neural Pathways | 2 | 2011 | 293 | 0.130 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 95 | 0.130 |
Why?
| | PPAR gamma | 1 | 2017 | 182 | 0.130 |
Why?
| | Dyslipidemias | 1 | 2018 | 177 | 0.130 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 308 | 0.130 |
Why?
| | Obesity, Morbid | 1 | 2000 | 238 | 0.130 |
Why?
| | Computational Biology | 1 | 2020 | 598 | 0.130 |
Why?
| | Receptors, Androgen | 1 | 2017 | 143 | 0.130 |
Why?
| | Alloxan | 1 | 2015 | 4 | 0.130 |
Why?
| | Fibroblasts | 2 | 2017 | 939 | 0.130 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 4 | 2019 | 57 | 0.130 |
Why?
| | Glucokinase | 1 | 2015 | 13 | 0.130 |
Why?
| | Hypothalamus | 1 | 2016 | 144 | 0.130 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 14 | 0.130 |
Why?
| | Down-Regulation | 3 | 2008 | 634 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 720 | 0.120 |
Why?
| | Malonyl Coenzyme A | 1 | 1995 | 5 | 0.120 |
Why?
| | Methylnitrosourea | 2 | 2018 | 7 | 0.120 |
Why?
| | Pediatric Obesity | 1 | 2022 | 572 | 0.120 |
Why?
| | Trophoblasts | 1 | 2017 | 190 | 0.120 |
Why?
| | Cholesterol, LDL | 3 | 2003 | 361 | 0.120 |
Why?
| | Caffeine | 1 | 1995 | 62 | 0.120 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 450 | 0.120 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1044 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 259 | 0.120 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 224 | 0.110 |
Why?
| | Infant | 5 | 2023 | 8992 | 0.110 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 493 | 0.110 |
Why?
| | Research Report | 1 | 2014 | 73 | 0.110 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2005 | 37 | 0.110 |
Why?
| | Circadian Rhythm | 2 | 2009 | 409 | 0.110 |
Why?
| | United States | 3 | 2023 | 13938 | 0.110 |
Why?
| | Mitochondria | 3 | 2022 | 854 | 0.110 |
Why?
| | Acinar Cells | 1 | 2013 | 13 | 0.110 |
Why?
| | Bariatric Surgery | 1 | 2017 | 192 | 0.110 |
Why?
| | Pantothenic Acid | 1 | 2013 | 5 | 0.110 |
Why?
| | Mitochondria, Liver | 1 | 2013 | 73 | 0.110 |
Why?
| | Birth Weight | 1 | 2016 | 499 | 0.110 |
Why?
| | Vitamin A Deficiency | 1 | 2013 | 27 | 0.100 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1671 | 0.100 |
Why?
| | Vitamin A | 1 | 2013 | 55 | 0.100 |
Why?
| | Intestinal Mucosa | 2 | 2015 | 579 | 0.100 |
Why?
| | Extracellular Space | 1 | 2013 | 120 | 0.100 |
Why?
| | Integrases | 1 | 2013 | 118 | 0.100 |
Why?
| | DNA Methylation | 1 | 2017 | 605 | 0.100 |
Why?
| | Oxidative Phosphorylation | 1 | 2013 | 184 | 0.100 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.100 |
Why?
| | Up-Regulation | 2 | 2013 | 828 | 0.100 |
Why?
| | Cytoskeleton | 1 | 2013 | 180 | 0.100 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 818 | 0.100 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 811 | 0.100 |
Why?
| | Cell Separation | 1 | 2013 | 313 | 0.100 |
Why?
| | Histones | 1 | 2017 | 584 | 0.100 |
Why?
| | Hormones | 2 | 2010 | 140 | 0.100 |
Why?
| | Epithelial Cells | 2 | 2020 | 1036 | 0.100 |
Why?
| | Research Design | 1 | 2018 | 1040 | 0.100 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 2002 | 37 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 156 | 0.090 |
Why?
| | Biomarkers | 6 | 2019 | 3896 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2013 | 299 | 0.090 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 177 | 0.090 |
Why?
| | Colon | 1 | 2013 | 251 | 0.090 |
Why?
| | Multienzyme Complexes | 2 | 2001 | 69 | 0.090 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2024 | 0.090 |
Why?
| | Glycolysis | 1 | 2012 | 293 | 0.090 |
Why?
| | Infant, Newborn | 3 | 2018 | 5739 | 0.090 |
Why?
| | Pulmonary Alveoli | 1 | 2013 | 366 | 0.090 |
Why?
| | Patient Compliance | 1 | 2014 | 562 | 0.090 |
Why?
| | Colorado | 2 | 2019 | 4394 | 0.090 |
Why?
| | Lipoproteins, VLDL | 2 | 2000 | 22 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 357 | 0.080 |
Why?
| | Metalloproteases | 1 | 2010 | 43 | 0.080 |
Why?
| | Acetaminophen | 1 | 2012 | 251 | 0.080 |
Why?
| | Perilipin-2 | 3 | 2015 | 36 | 0.080 |
Why?
| | Alkylating Agents | 1 | 2009 | 24 | 0.080 |
Why?
| | Bone and Bones | 1 | 2012 | 302 | 0.080 |
Why?
| | Mitochondrial Proteins | 2 | 2010 | 245 | 0.080 |
Why?
| | Adolescent | 6 | 2025 | 20301 | 0.080 |
Why?
| | Species Specificity | 1 | 2011 | 570 | 0.080 |
Why?
| | Fats | 1 | 2009 | 14 | 0.080 |
Why?
| | Young Adult | 6 | 2025 | 12389 | 0.080 |
Why?
| | Hypoglycemic Agents | 2 | 2017 | 1217 | 0.080 |
Why?
| | Hypertension | 1 | 2018 | 1243 | 0.080 |
Why?
| | Cholesterol, HDL | 2 | 2000 | 203 | 0.080 |
Why?
| | Glucose Clamp Technique | 2 | 2018 | 195 | 0.080 |
Why?
| | Health Behavior | 1 | 2014 | 740 | 0.080 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 312 | 0.080 |
Why?
| | Interleukin-4 | 1 | 2009 | 213 | 0.080 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 143 | 0.080 |
Why?
| | Self Report | 1 | 2013 | 806 | 0.080 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2014 | 190 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2267 | 0.070 |
Why?
| | Disease Susceptibility | 3 | 2016 | 335 | 0.070 |
Why?
| | Interleukin-2 | 1 | 2009 | 431 | 0.070 |
Why?
| | Cross-Over Studies | 2 | 2021 | 513 | 0.070 |
Why?
| | Risk Factors | 3 | 2018 | 9767 | 0.070 |
Why?
| | Treatment Outcome | 3 | 2016 | 10226 | 0.070 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2007 | 22 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1687 | 0.070 |
Why?
| | Hyperplasia | 1 | 2008 | 170 | 0.070 |
Why?
| | Antigens, CD34 | 1 | 2007 | 89 | 0.070 |
Why?
| | Patient Selection | 2 | 2009 | 665 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 175 | 0.070 |
Why?
| | Body Temperature Regulation | 1 | 2008 | 99 | 0.070 |
Why?
| | Leukocyte Count | 1 | 2007 | 328 | 0.070 |
Why?
| | Cell Line | 3 | 2019 | 2737 | 0.070 |
Why?
| | Gene Expression Profiling | 1 | 2013 | 1689 | 0.070 |
Why?
| | Lactates | 3 | 1995 | 83 | 0.060 |
Why?
| | Exercise Test | 1 | 2009 | 615 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2022 | 718 | 0.060 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 164 | 0.060 |
Why?
| | Calorimetry | 3 | 2012 | 67 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 60 | 0.060 |
Why?
| | Gluconeogenesis | 1 | 2006 | 73 | 0.060 |
Why?
| | Retrospective Studies | 3 | 2018 | 14571 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 1901 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1363 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 780 | 0.060 |
Why?
| | Models, Biological | 2 | 2018 | 1695 | 0.060 |
Why?
| | Lipolysis | 1 | 2005 | 40 | 0.060 |
Why?
| | Glucose Transporter Type 4 | 2 | 2002 | 39 | 0.060 |
Why?
| | Sterol Regulatory Element Binding Protein 2 | 1 | 2005 | 8 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2019 | 3342 | 0.060 |
Why?
| | Proteins | 2 | 2013 | 936 | 0.060 |
Why?
| | Pilot Projects | 2 | 2022 | 1567 | 0.060 |
Why?
| | Antigens, CD | 1 | 2007 | 483 | 0.060 |
Why?
| | Macrophages | 1 | 2012 | 1466 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 215 | 0.060 |
Why?
| | Kinetics | 2 | 2012 | 1617 | 0.060 |
Why?
| | Organ Specificity | 1 | 2005 | 291 | 0.060 |
Why?
| | Myogenic Regulatory Factors | 2 | 2001 | 56 | 0.060 |
Why?
| | MEF2 Transcription Factors | 2 | 2001 | 62 | 0.060 |
Why?
| | RNA, Small Interfering | 1 | 2006 | 571 | 0.050 |
Why?
| | Cholesterol, VLDL | 1 | 2003 | 4 | 0.050 |
Why?
| | Aged | 5 | 2018 | 22083 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 371 | 0.050 |
Why?
| | Food Deprivation | 1 | 2003 | 21 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 260 | 0.050 |
Why?
| | Protein Kinases | 2 | 2002 | 309 | 0.050 |
Why?
| | Absorptiometry, Photon | 1 | 2004 | 251 | 0.050 |
Why?
| | Hexokinase | 1 | 2022 | 18 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 18 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 16 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 1943 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 108 | 0.050 |
Why?
| | Lactic Acid | 4 | 2002 | 295 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 74 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 46 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 83 | 0.050 |
Why?
| | Rodentia | 1 | 2022 | 47 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 108 | 0.050 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 74 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 115 | 0.050 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 61 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2013 | 41 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 83 | 0.050 |
Why?
| | Dinoprostone | 1 | 2022 | 187 | 0.050 |
Why?
| | Mice, Obese | 1 | 2021 | 57 | 0.050 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2001 | 11 | 0.050 |
Why?
| | Neutrophils | 1 | 2007 | 1195 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2022 | 145 | 0.050 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 52 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 258 | 0.050 |
Why?
| | Diabetes Complications | 1 | 2003 | 224 | 0.050 |
Why?
| | Tumor Burden | 1 | 2022 | 283 | 0.050 |
Why?
| | Waist Circumference | 1 | 2021 | 138 | 0.050 |
Why?
| | Phospholipids | 1 | 2022 | 209 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2021 | 61 | 0.040 |
Why?
| | Drinking | 1 | 2021 | 41 | 0.040 |
Why?
| | Blotting, Southern | 1 | 2000 | 68 | 0.040 |
Why?
| | Intestines | 2 | 2015 | 349 | 0.040 |
Why?
| | Calmodulin | 1 | 2000 | 75 | 0.040 |
Why?
| | Hindlimb | 3 | 1995 | 125 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2022 | 687 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2018 | 7064 | 0.040 |
Why?
| | Calcineurin | 1 | 2000 | 91 | 0.040 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 93 | 0.040 |
Why?
| | Lipoproteins, HDL | 1 | 2000 | 85 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2000 | 266 | 0.040 |
Why?
| | Lipoproteins, LDL | 1 | 2000 | 126 | 0.040 |
Why?
| | Medicago sativa | 1 | 2019 | 1 | 0.040 |
Why?
| | Rumen | 1 | 2019 | 4 | 0.040 |
Why?
| | Dairying | 1 | 2019 | 7 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2019 | 14 | 0.040 |
Why?
| | Benzylamines | 1 | 2019 | 41 | 0.040 |
Why?
| | New Zealand | 1 | 2019 | 45 | 0.040 |
Why?
| | Protein Kinase C | 1 | 2000 | 253 | 0.040 |
Why?
| | Benzoates | 1 | 2019 | 41 | 0.040 |
Why?
| | Postprandial Period | 1 | 2019 | 103 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2022 | 378 | 0.040 |
Why?
| | Child | 2 | 2022 | 20805 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 203 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5068 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 26 | 0.040 |
Why?
| | Japan | 1 | 2018 | 98 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2019 | 128 | 0.040 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2019 | 130 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 274 | 0.040 |
Why?
| | Transfection | 1 | 2000 | 896 | 0.040 |
Why?
| | Neoplasms | 1 | 2012 | 2475 | 0.040 |
Why?
| | Stromal Cells | 1 | 2018 | 105 | 0.040 |
Why?
| | Sarcolemma | 1 | 2018 | 40 | 0.040 |
Why?
| | Nuclear Transfer Techniques | 1 | 2017 | 2 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2000 | 508 | 0.040 |
Why?
| | Comparative Genomic Hybridization | 1 | 2017 | 32 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 634 | 0.040 |
Why?
| | Cytokines | 2 | 2018 | 1987 | 0.040 |
Why?
| | Blastocyst | 1 | 2017 | 47 | 0.040 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 142 | 0.040 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 24 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1192 | 0.040 |
Why?
| | Muscle Contraction | 1 | 2000 | 421 | 0.040 |
Why?
| | Breast | 1 | 2018 | 153 | 0.040 |
Why?
| | Biological Specimen Banks | 1 | 2018 | 96 | 0.040 |
Why?
| | Phenylthiohydantoin | 1 | 2017 | 44 | 0.040 |
Why?
| | Cytosol | 1 | 2018 | 214 | 0.030 |
Why?
| | Cyclic AMP | 2 | 1995 | 230 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 161 | 0.030 |
Why?
| | Erythrocytes | 1 | 2022 | 672 | 0.030 |
Why?
| | Water Deprivation | 1 | 2016 | 8 | 0.030 |
Why?
| | Isoenzymes | 2 | 2012 | 304 | 0.030 |
Why?
| | Ectoderm | 1 | 2017 | 50 | 0.030 |
Why?
| | Epinephrine | 2 | 1994 | 138 | 0.030 |
Why?
| | Progesterone | 1 | 1998 | 244 | 0.030 |
Why?
| | Methylation | 1 | 2017 | 227 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2017 | 76 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1142 | 0.030 |
Why?
| | Nitriles | 1 | 2017 | 161 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2018 | 262 | 0.030 |
Why?
| | Steroids | 1 | 2017 | 148 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2017 | 184 | 0.030 |
Why?
| | Benzamides | 1 | 2017 | 195 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 356 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 144 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 103 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 579 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1010 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 816 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2017 | 171 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 375 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1192 | 0.030 |
Why?
| | Phosphocreatine | 1 | 1995 | 40 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 1865 | 0.030 |
Why?
| | Adenosine Monophosphate | 1 | 1995 | 62 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4010 | 0.030 |
Why?
| | Lipids | 1 | 1998 | 624 | 0.030 |
Why?
| | Fructosediphosphates | 1 | 1994 | 1 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 24 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1180 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 816 | 0.030 |
Why?
| | Perfusion | 1 | 1995 | 188 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 356 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1086 | 0.030 |
Why?
| | Hot Temperature | 1 | 2016 | 364 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 660 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3033 | 0.030 |
Why?
| | Testosterone | 1 | 2017 | 379 | 0.030 |
Why?
| | Cell Respiration | 1 | 2013 | 98 | 0.030 |
Why?
| | Laser Capture Microdissection | 1 | 2013 | 22 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 80 | 0.030 |
Why?
| | Betaine | 1 | 2013 | 72 | 0.030 |
Why?
| | Muscles | 1 | 1994 | 323 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 521 | 0.030 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2002 | 159 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 616 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1953 | 0.020 |
Why?
| | Collagen Type I | 1 | 2012 | 118 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 142 | 0.020 |
Why?
| | Intestine, Small | 1 | 2013 | 144 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2564 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1735 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2715 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 757 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 281 | 0.020 |
Why?
| | Metabolism | 1 | 2010 | 39 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2000 | 1671 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 500 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3184 | 0.020 |
Why?
| | Hypoglycemia | 1 | 1994 | 426 | 0.020 |
Why?
| | Glycerol | 1 | 2009 | 87 | 0.020 |
Why?
| | Liver Glycogen | 2 | 2002 | 17 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 431 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3260 | 0.020 |
Why?
| | Phenotype | 2 | 2008 | 3058 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 381 | 0.020 |
Why?
| | Birds | 1 | 2008 | 74 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 579 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 911 | 0.020 |
Why?
| | Body Temperature | 1 | 2008 | 216 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 35 | 0.020 |
Why?
| | Palmitates | 1 | 2006 | 18 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 7079 | 0.020 |
Why?
| | Orphan Nuclear Receptors | 1 | 2006 | 15 | 0.020 |
Why?
| | Breeding | 1 | 2006 | 62 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2006 | 31 | 0.020 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2006 | 31 | 0.020 |
Why?
| | PPAR alpha | 1 | 2006 | 59 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 31 | 0.020 |
Why?
| | Intestinal Absorption | 1 | 2006 | 96 | 0.020 |
Why?
| | Brain | 1 | 2018 | 2628 | 0.020 |
Why?
| | Adenoviridae | 1 | 2006 | 190 | 0.020 |
Why?
| | Enteral Nutrition | 1 | 2006 | 184 | 0.010 |
Why?
| | Introns | 1 | 2005 | 249 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2006 | 262 | 0.010 |
Why?
| | Enzymes | 1 | 2003 | 64 | 0.010 |
Why?
| | Uncoupling Protein 3 | 1 | 2002 | 8 | 0.010 |
Why?
| | Oxazoles | 1 | 2002 | 31 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2668 | 0.010 |
Why?
| | Ketones | 1 | 2002 | 47 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 115 | 0.010 |
Why?
| | Ion Channels | 1 | 2002 | 127 | 0.010 |
Why?
| | Ribonucleotides | 1 | 2001 | 24 | 0.010 |
Why?
| | Tyrosine | 1 | 2002 | 218 | 0.010 |
Why?
| | Aging | 1 | 2010 | 1771 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 799 | 0.010 |
Why?
| | RNA | 1 | 2003 | 883 | 0.010 |
Why?
| | Administration, Oral | 1 | 1998 | 759 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 7 | 0.010 |
Why?
| | Molecular Weight | 1 | 1995 | 331 | 0.010 |
Why?
| | Phosphofructokinase-1 | 1 | 1994 | 7 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 323 | 0.010 |
Why?
| | Cyclic GMP | 1 | 1994 | 85 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 3120 | 0.010 |
Why?
| | Blotting, Western | 1 | 1995 | 1169 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1994 | 463 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|